220 related articles for article (PubMed ID: 21415398)
1. Botulinum Toxin for the Upper Limb after Stroke (BoTULS) Trial: effect on impairment, activity limitation, and pain.
Shaw LC; Price CI; van Wijck FM; Shackley P; Steen N; Barnes MP; Ford GA; Graham LA; Rodgers H;
Stroke; 2011 May; 42(5):1371-9. PubMed ID: 21415398
[TBL] [Abstract][Full Text] [Related]
2. BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A.
Shaw L; Rodgers H; Price C; van Wijck F; Shackley P; Steen N; Barnes M; Ford G; Graham L;
Health Technol Assess; 2010 May; 14(26):1-113, iii-iv. PubMed ID: 20515600
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of botulinum toxin A in upper limb function of hemiplegic patients.
Rousseaux M; Kozlowski O; Froger J
J Neurol; 2002 Jan; 249(1):76-84. PubMed ID: 11954872
[TBL] [Abstract][Full Text] [Related]
4. Systematic review of upper-limb function measurement methods in botulinum toxin intervention for focal spasticity.
Ashford S; Turner-Stokes L
Physiother Res Int; 2013 Sep; 18(3):178-89. PubMed ID: 23630050
[TBL] [Abstract][Full Text] [Related]
5. Does low-dose botulinum toxin help the recovery of arm function when given early after stroke? A phase II randomized controlled pilot study to estimate effect size.
Cousins E; Ward A; Roffe C; Rimington L; Pandyan A
Clin Rehabil; 2010 Jun; 24(6):501-13. PubMed ID: 20483887
[TBL] [Abstract][Full Text] [Related]
6. Botulinum toxin type A for upper limb spasticity following stroke: an open-label study with individualised, flexible injection regimens.
Slawek J; Bogucki A; Reclawowicz D
Neurol Sci; 2005 Apr; 26(1):32-9. PubMed ID: 15877185
[TBL] [Abstract][Full Text] [Related]
7. Use of botulinum toxin in stroke patients with severe upper limb spasticity.
Bhakta BB; Cozens JA; Bamford JM; Chamberlain MA
J Neurol Neurosurg Psychiatry; 1996 Jul; 61(1):30-5. PubMed ID: 8676154
[TBL] [Abstract][Full Text] [Related]
8. Evaluating the functional outcomes of ultrasound-guided botulinum toxin type A injections using the Euro-musculus approach for upper limb spasticity treatment in post-stroke patients: an observational study.
Buyukavci R; Akturk S; Ersoy Y
Eur J Phys Rehabil Med; 2018 Oct; 54(5):738-744. PubMed ID: 29422486
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of spasticity with injections of botulinum toxin. Review of the literature].
Fève A; Decq P; Filipetti P; Kéravel Y
Neurochirurgie; 1998 Sep; 44(3):192-6. PubMed ID: 9827435
[TBL] [Abstract][Full Text] [Related]
10. Combined botulinum toxin type A with modified constraint-induced movement therapy for chronic stroke patients with upper extremity spasticity: a randomized controlled study.
Sun SF; Hsu CW; Sun HP; Hwang CW; Yang CL; Wang JL
Neurorehabil Neural Repair; 2010 Jan; 24(1):34-41. PubMed ID: 19729582
[TBL] [Abstract][Full Text] [Related]
11. Study design and methods of the BoTULS trial: a randomised controlled trial to evaluate the clinical effect and cost effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A.
Rodgers H; Shaw L; Price C; van Wijck F; Barnes M; Graham L; Ford G; Shackley P; Steen N;
Trials; 2008 Oct; 9():59. PubMed ID: 18947418
[TBL] [Abstract][Full Text] [Related]
12. Botulinum toxin in post-stroke patients: stiffness modifications and clinical implications.
Miscio G; Del Conte C; Pianca D; Colombo R; Panizza M; Schieppati M; Pisano F
J Neurol; 2004 Feb; 251(2):189-96. PubMed ID: 14991354
[TBL] [Abstract][Full Text] [Related]
13. Letter by Munin et al regarding article, "Botulinum Toxin for the Upper Limb after Stroke (BoTULS) trial: effect on impairment, activity limitation, and pain".
Munin MC; Weber DJ; Skidmore ER
Stroke; 2011 Jul; 42(7):e412; author reply e413. PubMed ID: 21636823
[No Abstract] [Full Text] [Related]
14. Botulinum toxin to treat upper-limb spasticity in hemiparetic patients: analysis of function and kinematics of reaching movements.
Bensmail D; Robertson JV; Fermanian C; Roby-Brami A
Neurorehabil Neural Repair; 2010; 24(3):273-81. PubMed ID: 20067949
[TBL] [Abstract][Full Text] [Related]
15. Botulinum toxin type A in the treatment of upper extremity spasticity: a randomized, double-blind, placebo-controlled trial.
Simpson DM; Alexander DN; O'Brien CF; Tagliati M; Aswad AS; Leon JM; Gibson J; Mordaunt JM; Monaghan EP
Neurology; 1996 May; 46(5):1306-10. PubMed ID: 8628472
[TBL] [Abstract][Full Text] [Related]
16. Effect of Additional Rehabilitation After Botulinum Toxin-A on Upper Limb Activity in Chronic Stroke: The InTENSE Trial.
Lannin NA; Ada L; English C; Ratcliffe J; Faux SG; Palit M; Gonzalez S; Olver J; Cameron I; Crotty M;
Stroke; 2020 Feb; 51(2):556-562. PubMed ID: 31813359
[TBL] [Abstract][Full Text] [Related]
17. Evidence to practice: botulinum toxin in the treatment of spasticity post stroke.
Teasell R; Foley N; Pereira S; Sequeira K; Miller T
Top Stroke Rehabil; 2012; 19(2):115-21. PubMed ID: 22436359
[TBL] [Abstract][Full Text] [Related]
18. Botulinum toxin for treatment of spasticity in adults.
Reichel G
J Neurol; 2001 Apr; 248 Suppl 1():25-7. PubMed ID: 11357235
[TBL] [Abstract][Full Text] [Related]
19. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after stroke.
Jahangir AW; Tan HJ; Norlinah MI; Nafisah WY; Ramesh S; Hamidon BB; Raymond AA
Med J Malaysia; 2007 Oct; 62(4):319-22. PubMed ID: 18551937
[TBL] [Abstract][Full Text] [Related]
20. Botulinum Toxin Type A for Upper Limb Spasticity in Poststroke Patients: A Meta-analysis of Randomized Controlled Trials.
Jia S; Liu Y; Shen L; Liang X; Xu X; Wei Y
J Stroke Cerebrovasc Dis; 2020 Jun; 29(6):104682. PubMed ID: 32305277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
